Pediatric Autoimmune Encephalitis Following COVID-19 Infection
- PMID: 35014889
- PMCID: PMC9066234
- DOI: 10.1177/08830738211069814
Pediatric Autoimmune Encephalitis Following COVID-19 Infection
Abstract
Similar to the pathogenesis of autoimmune disease, SARS-CoV-2 (COVID-19) infection has been shown to be associated with dysregulated and persistent inflammatory reactions and production of some antibodies. We report 3 pediatric patients found to have serum SARS-CoV-2 antibodies who presented with neurologic findings suggestive of postinfectious autoimmune-mediated encephalitis. All 3 cases showed lymphocytic pleocytosis on cerebrospinal fluid studies and marked improvement in neurologic symptoms after high-dose intravenous corticosteroids. The manifestations of SARS-CoV-2 infection in the pediatric population are still an evolving area of study, and these cases suggest autoimmune-mediated encephalitis as yet another SARS-CoV-2 related complication.
Keywords: COVID-19, autoimmune, encephalitis, pediatrics, postinfectious.
Conflict of interest statement
Figures
References
-
- Román GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute transverse myelitis (ATM): clinical review of 43 patients With COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the Chadox1 nCoV-19 vaccine (AZD1222). Front Immunol. 2021;12. doi:10.3389/fimmu.2021.653786 - DOI - PMC - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
